Update on BTK Inhibition in Waldenströms Macroglobulinemia
Meletios A. Dimopoulos, MD
Professor and Chairman,
Department of Clinical Therapeutics
Natinal and Kapodistrian University
of Athens School of Medicine
The role of Bruton's tyrosine kinase, or BTK, inhibition in the management of B-cell malignancies, including the impact BTK occupancy and selectivity may have on deeper responses and improved outcomes.
Independent medical education program prepared by PeerDirect supported by BeiGene.